<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01222988</url>
  </required_header>
  <id_info>
    <org_study_id>10-002960</org_study_id>
    <nct_id>NCT01222988</nct_id>
  </id_info>
  <brief_title>Improving Maintenance Following Very Low Calorie Diet: The Sustain Lost Weight (SLW) Intervention</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obtain a preliminary assessment of the feasibility and acceptability of delivering the&#xD;
      sustained lost weight (SLW) intervention in a real-world clinical setting for patients who&#xD;
      have completed a 21-week very low calorie diet (VLCD).&#xD;
&#xD;
      Hypothesis: Intervention will be feasible to implement as evidenced by the ability to recruit&#xD;
      and retain participants and acceptable to participants as evidenced by self-report of&#xD;
      satisfaction with the program and adoption of weight maintenance behaviors.&#xD;
&#xD;
      Secondary Aim: Obtain a preliminary assessment of the effectiveness of the sustained lost&#xD;
      weight (SLW) intervention for patients who have completed 21 weeks of a very low calorie diet&#xD;
      (VLCD).&#xD;
&#xD;
      Hypothesis: Greater than 75% of participants who receive this novel approach, where&#xD;
      maintenance behaviors are individualized based on resting metabolic rate and a physical&#xD;
      activity factor, will regain greater or equal to 10 kg. at week 52 follow-up.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Feasibility</measure>
    <time_frame>52 weeks</time_frame>
    <description>Treatment will be considered feasible if greater than 50 % of participants attend a minimum of 17 of 20 sessions. The treatment will be considered acceptable for further study if greater than 50% of participants rate the maintenance program with a mean score of 6 or higher.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight Gain Analysis</measure>
    <time_frame>52 weeks</time_frame>
    <description>Weight regain from week 1 to 52 will be analyzed. Patients who discontinue the study or are lost to follow-up will be assumed to have gained more than 10 kg at 12 months.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>very low calorie diet program</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Optifast Products</intervention_name>
    <description>Optional Optifast products offered once every other week X 6 months; then monthly.</description>
    <arm_group_label>very low calorie diet program</arm_group_label>
    <other_name>Optifast Dietary Supplements</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Completed fast and transition period of the OPTIFASTÂ® program&#xD;
&#xD;
          -  Be able to participate fully in all aspects of the study&#xD;
&#xD;
          -  Willing to refrain from participating in additional weight loss interventions for the&#xD;
             duration of the study&#xD;
&#xD;
          -  Willing to provide written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Myocardial infarction within 6 months&#xD;
&#xD;
          -  Unstable angina&#xD;
&#xD;
          -  Stroke&#xD;
&#xD;
          -  Chronic steroid use&#xD;
&#xD;
          -  Active peptic ulcer disease&#xD;
&#xD;
          -  Advanced cirrhosis&#xD;
&#xD;
          -  Active hepatitis&#xD;
&#xD;
          -  Advanced renal disease&#xD;
&#xD;
          -  Active thrombophlebitis&#xD;
&#xD;
          -  Recent skeletal fractures&#xD;
&#xD;
          -  Use of lithium&#xD;
&#xD;
          -  Pancreatitis&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Type 1 diabetes mellitus&#xD;
&#xD;
          -  History of diabetic ketoacidosis&#xD;
&#xD;
          -  Active bulimia nervosa&#xD;
&#xD;
          -  Severe depression&#xD;
&#xD;
          -  Psychosis&#xD;
&#xD;
          -  Substance abuse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gretchen Ames, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>October 12, 2010</study_first_submitted>
  <study_first_submitted_qc>October 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2010</study_first_posted>
  <last_update_submitted>January 15, 2013</last_update_submitted>
  <last_update_submitted_qc>January 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 17, 2013</last_update_posted>
  <responsible_party>
    <name_title>Gretchen E. Ames, Ph.D.</name_title>
    <organization>Mayo Clinic</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

